[go: up one dir, main page]

BRPI0922008A2 - compostos e respectivos metodos de preparação - Google Patents

compostos e respectivos metodos de preparação

Info

Publication number
BRPI0922008A2
BRPI0922008A2 BRPI0922008A BRPI0922008A BRPI0922008A2 BR PI0922008 A2 BRPI0922008 A2 BR PI0922008A2 BR PI0922008 A BRPI0922008 A BR PI0922008A BR PI0922008 A BRPI0922008 A BR PI0922008A BR PI0922008 A2 BRPI0922008 A2 BR PI0922008A2
Authority
BR
Brazil
Prior art keywords
compounds
preparation methods
preparation
methods
Prior art date
Application number
BRPI0922008A
Other languages
English (en)
Inventor
Gregory J Haley
Original Assignee
Anadys Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anadys Pharmaceuticals Inc filed Critical Anadys Pharmaceuticals Inc
Publication of BRPI0922008A2 publication Critical patent/BRPI0922008A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
BRPI0922008A 2008-11-17 2009-11-16 compostos e respectivos metodos de preparação BRPI0922008A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11513408P 2008-11-17 2008-11-17
PCT/US2009/064605 WO2010057103A1 (en) 2008-11-17 2009-11-16 Method of preparing deoxyribofuranose compounds

Publications (1)

Publication Number Publication Date
BRPI0922008A2 true BRPI0922008A2 (pt) 2016-05-10

Family

ID=42170391

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922008A BRPI0922008A2 (pt) 2008-11-17 2009-11-16 compostos e respectivos metodos de preparação

Country Status (21)

Country Link
US (2) US8829168B2 (pt)
EP (1) EP2365753B1 (pt)
JP (1) JP5613168B2 (pt)
KR (1) KR101643661B1 (pt)
CN (1) CN102300464B (pt)
AU (1) AU2009313842B2 (pt)
BR (1) BRPI0922008A2 (pt)
CA (1) CA2743796C (pt)
DK (1) DK2365753T3 (pt)
EA (1) EA020552B1 (pt)
ES (1) ES2431269T3 (pt)
HK (1) HK1162856A1 (pt)
IL (1) IL212902A0 (pt)
MX (1) MX2011005170A (pt)
MY (1) MY159745A (pt)
NZ (1) NZ593021A (pt)
PL (1) PL2365753T3 (pt)
SI (1) SI2365753T1 (pt)
TW (1) TWI450904B (pt)
UA (1) UA103637C2 (pt)
WO (1) WO2010057103A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012089747A1 (en) * 2010-12-29 2012-07-05 Akzo Nobel Coatings International B.V. Latex emulsions and coating compositions formed from latex emulsions
CN103172682B (zh) * 2013-03-14 2015-11-18 北京瑞博奥生物科技有限公司 2-脱氧-l-呋喃核糖的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997043295A1 (fr) * 1996-05-16 1997-11-20 Taiho Pharmaceutical Co., Ltd. Derives de d-pentofuranose et leur procede de preparation
TR200601783T2 (tr) 1999-11-12 2007-01-22 Pharmasset Ltd 2'-Deoksi-L-nükleositlerin sentezi
US6863782B2 (en) * 2002-11-15 2005-03-08 A.P. Pharma, Inc. Method of preparing di(ketene acetals)
US7034167B2 (en) * 2002-12-06 2006-04-25 Merck & Co., Inc. Process to ribofuranose sugar derivatives as intermediates to branched-chain nucleosides
MXPA05013752A (es) * 2003-06-17 2006-03-08 Schering Corp Procedimiento e intermediarios para la preparacion de (1r,2s,5s)-6,6-dimetil-3-azabiciclo[3,1,0]exan-2-carboxilatos o sales de los mismos.
CN1878783A (zh) 2003-09-11 2006-12-13 弗·哈夫曼-拉罗切有限公司 制备抗病毒核苷衍生物的方法
JP2007137843A (ja) * 2005-11-21 2007-06-07 Sumitomo Chemical Co Ltd リボフラノース化合物およびプリンヌクレオシド化合物の製造方法
US20070225246A1 (en) * 2006-03-27 2007-09-27 Denu John M O-acetyl-ADP-ribose non-hydrolyzable analogs
CN101172989B (zh) * 2006-11-03 2012-06-06 上海睿智化学研究有限公司 5-O-乙酰基-3-脱氧-1,2-异亚丙基-α-D-呋喃木糖的制备方法及一种中间体
BRPI0906448A2 (pt) * 2008-01-10 2015-07-14 Sun Pharma Advanced Res Co Ltd Novos derivados do acil cyanopyrrolidines

Also Published As

Publication number Publication date
CN102300464A (zh) 2011-12-28
HK1162856A1 (en) 2012-09-07
TWI450904B (zh) 2014-09-01
CA2743796A1 (en) 2010-05-20
US20140350231A1 (en) 2014-11-27
EA201170702A1 (ru) 2011-12-30
TW201028430A (en) 2010-08-01
IL212902A0 (en) 2011-07-31
CA2743796C (en) 2016-10-25
SI2365753T1 (sl) 2014-01-31
AU2009313842A1 (en) 2010-05-20
KR20110084542A (ko) 2011-07-25
MX2011005170A (es) 2011-05-30
PL2365753T3 (pl) 2013-12-31
US20110288282A1 (en) 2011-11-24
KR101643661B1 (ko) 2016-07-28
UA103637C2 (uk) 2013-11-11
NZ593021A (en) 2013-04-26
DK2365753T3 (da) 2013-10-21
MY159745A (en) 2017-01-31
US9227992B2 (en) 2016-01-05
EP2365753A4 (en) 2012-07-04
CN102300464B (zh) 2014-11-12
ES2431269T3 (es) 2013-11-25
JP2012509268A (ja) 2012-04-19
US8829168B2 (en) 2014-09-09
JP5613168B2 (ja) 2014-10-22
WO2010057103A1 (en) 2010-05-20
EP2365753B1 (en) 2013-07-17
AU2009313842B2 (en) 2015-08-20
EP2365753A1 (en) 2011-09-21
EA020552B1 (ru) 2014-12-30

Similar Documents

Publication Publication Date Title
HK1196358A1 (zh) 取代的吡啶- -酮和噠嗪- -酮
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
DE602009000234D1 (de) msignals
BRPI0907376A2 (pt) Fotobiorretador
DE602008003972D1 (de) Sitzrücklehnungsmechanismus
DE602008003521D1 (de) Sitzrücklehnungsmechanismus
FIC20240018I1 (fi) Vamoroloni
DK2336132T3 (da) Morpholinpurinderivat
DK2335031T3 (da) In-line-måler
EP2207803A4 (en) Cd9-specific human antibodies
DK2125048T3 (da) Præparat
BRPI0923527A2 (pt) métodos de preparo de fungicidas
FI8206U1 (fi) Kanylointisimulantti
DK2271613T3 (da) Hydroxymethylcyklohexylaminer
DE602008003970D1 (de) Strahlstromkalibriersystem
BRPI0814876A2 (pt) Análogos de pirona fosforilados e métodos
BRPI0911625A2 (pt) Métodos
EP2350385A4 (en) Forming section
EP2257170A4 (en) TETRAHYDROFUROPYRIDONE
BRPI0915562A2 (pt) tamis melhorado
BRPI0915442A2 (pt) tamis melhorado
BRPI0907522A2 (pt) biarlamidas
DE112009000183A5 (de) Sicherheitsvorreiber
SMT201500273B (it) Diidroetorfine e loro preparazione
BRPI0909634A2 (pt) 2-aminoquinolinas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.11 PUBLICADO NA RPI 2421 DE 30/05/2017.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]